[1]Christiansen,Elisabeth;Hansen,SteffenV.F.;Urban,Christian;Hudson,BrianD.;Wargent,EdwardT.;Grundmann,Manuel;Jenkins,Laura;Zaibi,Mohamed;Stocker,ClaireJ.;Ullrich,Susanne;Kostenis,Evi;Kassack,MatthiasU.;Milligan,Graeme;Cawthorne,MichaelA.;Ulven,Trond[ACSMedicinalChemistryLetters,2013,vol.4,#5,p.441-445]
Title: Development and Characterization of a Potent Free Fatty Acid Receptor 1 (FFA1) Fluorescent Tracer.
Journal: Journal of medicinal chemistry 20160526
Title: Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes.
Journal: ACS medicinal chemistry letters 20130509
Title: The role of biotransformation in the action of drugs affecting the sympathetic nervous system.
Journal: International anesthesiology clinics 19750101
Title: Christiansen E, et al. Discovery of TUG-770: A Highly Potent Free Fatty Acid Receptor 1 (FFA1/GPR40) Agonist for Treatment of Type 2 Diabetes. ACS Med Chem Lett. 2013 May 9;4(5):441-445.
